webinar register page

VSHP-Dynamics in the Biosimilar Landscape: Recent and Upcoming Changes
Speaker:
Mark Maas, PharmD, BCPS
Clinical Pharmacy Specialist, Drug Information and Policy
Department of Pharmacy Services, VCU Health System

Presentation Objectives for Pharmacists:
1. Define biosimilar, interchangeable, and unbranded biologic.
2. Determine the optimal infliximab biosimilar for your institution.
3. Prepare your institution for the marketing of adalimumab biosimilars.
Presentation Objectives for Pharmacy Technicians:
1. Define biosimilar, interchangeable, and unbranded biologic.
2. List the steps taken to assess infliximab biosimilars at your institution.
3. Prepare your institution for the marketing of adalimumab biosimilars.

Dec 8, 2022 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading